As of 2024-12-15, the Intrinsic Value of Bioatla Inc (BCAB) is
-8.46 USD. This Bioatla valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.45 USD, the upside of Bioatla Inc is
-683.51%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-8.46 USD
Intrinsic Value
Bioatla Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-8.46 - -8.46 |
-8.46 |
-683.51% |
| P/E |
(35.06) - (32.52) |
(37.90) |
-2714.1% |
| DDM - Stable |
(8.96) - (24.86) |
(16.91) |
-1266.2% |
| DDM - Multi |
(1.23) - (2.67) |
(1.68) |
-216.2% |
Bioatla Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
70.11 |
| Beta |
3.66 |
| Outstanding shares (mil) |
48.35 |
| Enterprise Value (mil) |
13.59 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.67% |
| Cost of Debt |
5.00% |
| WACC |
8.67% |